Mrs Sheila Chile, | |
1736 Main St S, Greenwood, SC 29646-4124 | |
(864) 942-3600 | |
(864) 942-3690 |
Full Name | Mrs Sheila Chile |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 1736 Main St S, Greenwood, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689093874 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | LPN.38122 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Sheila Chile, 1736 Main St S, Greenwood, SC 29646-4124 Ph: (864) 942-3600 | Mrs Sheila Chile, 1736 Main St S, Greenwood, SC 29646-4124 Ph: (864) 942-3600 |
News Archive
Traditionally, geneticists divide disorders into "simple," where a single gene mutation causes disease, or complex, where mutations in many genes contribute modest amounts. A new study suggests that the truth is somewhere in between.
A recent audit gave the state Department of Community Health a "clean report" but also found that the agency overspent its Medicaid budget by $32 million in fiscal 2012. The audit findings were discussed at an agency board meeting Thursday.
Unflued gas heaters in public schools posed a risk of respiratory ailments to students, a report found. Education Minister Verity Firth announced yesterday that the NSW government will replace these heaters. The government funded study to look at the effects of these low-emission unflued gas heaters in NSW public schools found "no measurable adverse changes in lung function" but said it was important to seek "alternative, effective and efficient sources of domestic and public space heating that does not have adverse effects".
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
A clinician scientist at Massachusetts General Hospital in Boston is receiving $240,000 to further his research into how stem cells may be used to treat Parkinson's disease through the American Academy of Neurology Foundation and the Parkinson's Disease Foundation Clinician Scientist Development Award in Parkinson's Disease Research.
› Verified 6 days ago
Ms. Julie C. Allen, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1410 W Alexander Ave, Greenwood, SC 29646 Phone: 864-229-4301 Fax: 864-229-4839 | |
Cynthia Baker, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1547 Parkway, Greenwood, SC 29646 Phone: 864-229-7120 | |
Trinity Herndon, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1736 Main St S, Greenwood, SC 29646 Phone: 864-227-5993 |